Switching From Preserved to Preserved-free Treatments for Glaucoma.
Status:
Unknown status
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
A 1-year prospective, randomized, investigator-masked trial comparing the confocal and
clinical effects of treatment with unpreserved prostaglandins (tafluprost) versus preserved
prostaglandins (latanoprost) in newly-diagnosed glaucoma patients.